Literature DB >> 1387201

Treatment of iris melanoma with photodynamic therapy.

J Davidorf1, F Davidorf.   

Abstract

Photodynamic therapy was used to treat four patients with iris melanoma. Hematoporphyrin derivative was used as a sensitizing agent. The tumors were exposed to a total dose of 1.72 x 10(6) J/cm2 of 630-nanometer laser light. The eye of the first patient, enucleated after treatment, histopathologically showed significant tumor necrosis. The tumors in the three subsequent patients were almost completely ablated, with no evidence of regrowth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387201

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

1.  Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study.

Authors:  Arno Hueber; Salvatore Grisanti; Michael Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

2.  [Photodynamic therapy with verteporfin for uveal melanoma].

Authors:  J Wachtlin; N E Bechrakis; M H Foerster
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

3.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

4.  Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma.

Authors:  Nikolaos Trichopoulos; Bertil Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-12       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.